James W. Carroll
James W. Carroll Jr. is an American attorney and government appointee, currently serving as director of the Office of National Drug Control Policy in the Trump Administration since February 9, 2018.[1][2]
Jim Carroll | |
---|---|
Director of the Office of National Drug Control Policy | |
In office January 3, 2019 – January 20, 2021 Acting: February 9, 2018 – January 3, 2019 | |
President | Donald Trump |
Preceded by | Rich Baum (Acting) |
Succeeded by | Regina LaBelle (Acting) |
White House Principal Deputy Chief of Staff | |
In office December 6, 2017 – February 9, 2018 | |
President | Donald Trump |
Preceded by | Kirstjen Nielsen |
Succeeded by | Zachary Fuentes |
Personal details | |
Political party | Republican |
Education | University of Virginia (BA) George Mason University (JD) |
After being confirmed by the U.S. Senate on January 2, 2019, he was sworn in by Vice President Mike Pence on January 31.[3] Earlier, Carroll had served as the White House Deputy Chief of Staff.[4] Prior to that he was General Counsel in the Office of Management and Budget, and an attorney in the Office of the White House Counsel for Presidents Donald Trump and George W. Bush.[5]
References
- "President Donald J. Trump Announces Appointments for the Executive Office of the President". The White House. Retrieved February 9, 2018.
- "PN1864 — James W. Carroll Jr. — Executive Office of the President". U.S. Congress. Retrieved April 26, 2018.
- "APhA Attends Swearing-In Ceremony of National Drug Control Policy Director". American Pharmacists Association. February 4, 2019. Retrieved March 16, 2019.
- Restuccia, Andrew; Karni, Annie (December 21, 2017). "Trump eyes former aides as West Wing staffers depart". Politico.
- "President Donald J. Trump Announces Key Additions to the Office of the White House Counsel". The White House. Retrieved March 7, 2017.
External links
- Media related to James W. Carroll at Wikimedia Commons
Political offices | ||
---|---|---|
Preceded by Rich Baum Acting |
Director of the Office of National Drug Control Policy 2018–present Acting: 2018–2019 |
Incumbent |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.